iBio, Inc. 8-K

What Happened
On February 10, 2026, iBio, Inc. announced its financial results for the quarter ended December 31, 2025 and furnished the press release as Exhibit 99.1 to a Current Report on Form 8‑K (Item 2.02). The 8‑K also includes the embedded Interactive XBRL cover page (Exhibit 104). The filing was signed by Marc A. Banjak, Chief Legal Officer. The Form 8‑K itself furnishes the press release but does not include additional financial tables beyond what is disclosed in that press release.

Key Details

• Filing date: February 10, 2026 (Form 8‑K).
• Reporting period: Quarter ended December 31, 2025.
• Exhibit furnished: 99.1 — Press Release announcing the quarter’s results.
• Interactive data: Exhibit 104 — Cover Page Interactive Data File (Inline XBRL).

Why It Matters
This 8‑K is the company’s timely disclosure that the quarter‑end results are available; investors should read the attached press release for specifics (revenue, net income/loss, cash position, guidance or material changes). Because the Form 8‑K only furnishes the press release, any material financial or operational details and management commentary will be in that press release or in subsequent filings (e.g., 10‑Q). No executive changes or other corporate actions are reported in this filing.